TNX-224

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameTNX-224
Drug Alias Name166-32
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionComplement factor D inhibitors
TargetsComplement factor D
Therapy Area/IndicationsReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTanox Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTanox Inc
Active IndicationsN/A
Inactive IndicationsReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A